Disease-specific overall survival in endometrioid ovarian

Our goal is always the complete removal of the disease

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial - The Lancet Oncology

From New Molecular Insights to New Treatment Options in Endometrial Cancer

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study - The Lancet Oncology

CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma

Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade - ScienceDirect

Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer

Study reveals factors in metabolism that can

Disease-specific overall survival in endometrioid ovarian carcinoma

Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary

Full article: The effect of adenomyosis on endometrial cancer: a university hospital-based cohort study

Diagnostics, Free Full-Text

Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions